Novo Nordisk, Teva ink generic Victoza settlementTeva is licensed to launch a generic version of Victoza as of Dec. 22, 2023 as the result of its settlement with Novo Nordisk, which manufactures the branded version of the drug. FDA approves Zydus Cadila’s generic Zovirax ointmentZydus Cadila's generic Zovirax will be available in 5% strength. FDA gives tentative nod for Perrigo’s generic Finacea Finacea foam had a market value of roughly $62 million for the 12 months ended January 2019. Zydus Cadila gets FDA clearance for generic Diovan Zydus Cadila's generic Diovan tablets come in several dosage strengths. Glenmark receives FDA approval for generic BenzaClin gel BenzaClin gel had a market value of roughly $99.4 million for the 12 months ended January 2019. Zydus Cadila gets tentative FDA approval for generic Janumet XR Zydus Cadila's generic Janumet will give Type 2 diabetes patients another treatment option. Alkem gets FDA nod for generic Diovan Alkem's generic Diovan is expected to help relieve a recent shortage of valsartan. Amneal introduces generic Exelon Patch The rivastigmine transdermal system had a market value of approximately $214 million for the 12 months ended January 2019. AAM raises concern over Trump budget's potential exclusivity changes The Association for Accessible Medicines criticized the Administration's proposal to amend the 180-day period of exclusivity for first generics. Lannett to distribute generic Adderall Adderall, including generic versions, had a market value of about $361 million for the 12 months ended January 2019, Lannett said. First Previous 196 197 198 199 200 Next Last
